These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 2575692

  • 21. Improvement of hepatic encephalopathy treated with flumazenil.
    Grimm G, Ferenci P, Katzenschlager R, Madl C, Schneeweiss B, Laggner AN, Lenz K, Gangl A.
    Lancet; 1988 Dec 17; 2(8625):1392-4. PubMed ID: 2904525
    [Abstract] [Full Text] [Related]

  • 22. An interaction between benzodiazepines and neuroactive steroids at GABA A receptors in cultured hippocampal neurons.
    Ahboucha S, Coyne L, Hirakawa R, Butterworth RF, Halliwell RF.
    Neurochem Int; 2006 Jun 17; 48(8):703-7. PubMed ID: 16487630
    [Abstract] [Full Text] [Related]

  • 23. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.
    Bassett ML, Mullen KD, Skolnick P, Jones EA.
    Gastroenterology; 1987 Nov 17; 93(5):1069-77. PubMed ID: 2820828
    [Abstract] [Full Text] [Related]

  • 24. Benzodiazepine receptor antagonists for hepatic encephalopathy.
    Als-Nielsen B, Gluud LL, Gluud C.
    Cochrane Database Syst Rev; 2004 Nov 17; (2):CD002798. PubMed ID: 15106178
    [Abstract] [Full Text] [Related]

  • 25. [The action of the benzodiazepine antagonist Ro 15-1788].
    Doenicke A, Suttmann H, Kapp W, Kugler J, Ebentheuer H.
    Anaesthesist; 1984 Aug 17; 33(8):343-7. PubMed ID: 6148904
    [Abstract] [Full Text] [Related]

  • 26. Flumazenil in benzodiazepine antagonism. Actions and clinical use in intoxications and anaesthesiology.
    Amrein R, Leishman B, Bentzinger C, Roncari G.
    Med Toxicol Adverse Drug Exp; 1987 Aug 17; 2(6):411-29. PubMed ID: 2893240
    [Abstract] [Full Text] [Related]

  • 27. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
    Cadranel JF, el Younsi M, Pidoux B, Zylberberg P, Benhamou Y, Valla D, Opolon P.
    Eur J Gastroenterol Hepatol; 1995 Apr 17; 7(4):325-9. PubMed ID: 7600138
    [Abstract] [Full Text] [Related]

  • 28. [Mixed benzodiazepine poisoning and reversal with flumazenil (Ro 15-1788)].
    Rivas López FA, López Soriano F, Mendoza Cerezo A, Jiménez Ferré J, Azurmendi Rodríguez JI, de la Rubia Nieto MA.
    Rev Esp Anestesiol Reanim; 1989 Apr 17; 36(1):48-50. PubMed ID: 2565591
    [Abstract] [Full Text] [Related]

  • 29. [Therapeutic management of hepatic encephalopathy].
    Helewski KJ, Kowalczyk-Ziomek GI, Konecki JJ.
    Wiad Lek; 2002 Apr 17; 55(5-6):301-9. PubMed ID: 12235697
    [Abstract] [Full Text] [Related]

  • 30. [Chronic hepatic encephalopathy treated by long-term intravenous administration of flumazenil in ambulatory care].
    Péroux JL, Paolini O, Tran A, Frappa B, Rampal P.
    Gastroenterol Clin Biol; 1996 Feb 17; 20(1):106-8. PubMed ID: 8734316
    [Abstract] [Full Text] [Related]

  • 31. [Evaluation of the therapeutic effect of flumazenil in hepatic encephalopathy using cerebral cartography].
    Bello Mimbrera G, García de León M, de la Torre Gutiérrez S, Montero Vázquez J, Torres Salcines J, de la Torre Fernández JM.
    Rev Esp Enferm Apar Dig; 1989 Mar 17; 75(3):277-9. PubMed ID: 2499914
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis.
    Ozyilkan E, Kahraman H, Onar M, Kesim G, Arik Z.
    East Afr Med J; 1997 Apr 17; 74(4):210-2. PubMed ID: 9299818
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Clinical experience in benzodiazepine antagonist].
    Hung DZ, Deng JF, Tsai WJ.
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Feb 17; 47(2):121-5. PubMed ID: 1672103
    [Abstract] [Full Text] [Related]

  • 37. Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.
    Rothstein JD, Olasmaa M.
    Neurochem Res; 1990 Feb 17; 15(2):193-7. PubMed ID: 2159124
    [Abstract] [Full Text] [Related]

  • 38. [Participation of GABA--benzodiazepine receptor complex in the anxiolytic effect of piracetam].
    Moldavkin GM, Voronina TA, Neznamov GG, Maletova OK, Eliava NV.
    Eksp Klin Farmakol; 2006 Feb 17; 69(3):7-9. PubMed ID: 16878489
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.